Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 22491513)

1.

Secretory carcinoma of breast demonstrates nuclear or cytoplasmic expression in p63 immunohistochemistry.

Choi J, Kim D, Koo JS.

Int J Surg Pathol. 2012 Aug;20(4):367-72. doi: 10.1177/1066896912440506. Epub 2012 Apr 4.

PMID:
22491513
2.

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.

Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C.

Am J Surg Pathol. 2001 Aug;25(8):1054-60.

PMID:
11474290
3.

p63 expression in benign and malignant breast lesions.

Stefanou D, Batistatou A, Nonni A, Arkoumani E, Agnantis NJ.

Histol Histopathol. 2004 Apr;19(2):465-71.

PMID:
15024707
4.
5.

CD24 expression has a prognostic impact in breast carcinoma.

Athanassiadou P, Grapsa D, Gonidi M, Athanassiadou AM, Tsipis A, Patsouris E.

Pathol Res Pract. 2009;205(8):524-33. doi: 10.1016/j.prp.2009.01.008. Epub 2009 Feb 24.

PMID:
19243896
6.

Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.

Martin SE, Temm CJ, Goheen MP, Ulbright TM, Hattab EM.

Mod Pathol. 2011 Oct;24(10):1320-6. doi: 10.1038/modpathol.2011.89. Epub 2011 May 27.

7.
8.

The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.

Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW.

J Clin Pathol. 2007 Mar;60(3):315-20. Epub 2006 May 12.

9.

Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast.

Kawaguchi K, Shin SJ.

Am J Surg Pathol. 2012 Jul;36(7):1009-20. doi: 10.1097/PAS.0b013e31824e0f90.

PMID:
22446941
10.

Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.

Zheng HC, Saito H, Masuda S, Wang ZG, Takano Y.

Appl Immunohistochem Mol Morphol. 2008 Oct;16(5):459-65. doi: 10.1097/PAI.0b013e3181640bb1.

PMID:
18665036
11.

Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.

Grunewald TG, Kammerer U, Kapp M, Eck M, Dietl J, Butt E, Honig A.

BMC Cancer. 2007 Oct 23;7:198.

12.

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.

Breast Cancer Res Treat. 2006 Jun;97(3):275-83. Epub 2005 Dec 13.

PMID:
16344916
13.

Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.

Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB.

J Pathol. 2005 Apr;205(5):585-91.

PMID:
15776477
15.

The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.

Zheng HC, Xia P, Xu XY, Takahashi H, Takano Y.

Hum Pathol. 2011 Mar;42(3):424-33. doi: 10.1016/j.humpath.2009.12.018. Epub 2010 Dec 28.

PMID:
21193223
16.
17.

p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?

de Moraes Schenka NG, Schenka AA, de Souza Queiroz L, de Almeida Matsura M, Alvarenga M, Vassallo J.

Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):71-7.

PMID:
16540734
18.

Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis.

Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, Ogata Y, Nakashima O, Kage M, Yano H.

Jpn J Clin Oncol. 2010 Aug;40(8):781-7. doi: 10.1093/jjco/hyq056. Epub 2010 May 5.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk